Product Information

OMEPRAZOLE-BICARB 20-1,680 PKT is a generic product labeled by Strides Pharma Inc., priced at $7.8063 per EA under NDC 64380018202. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the omeprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OMEPRAZOLE-BICARB 20-1,680 PKT

omeprazole
$7.8063per EA
High Outlier

Strength

20; 1680 mg/1700mg; mg/1700mg

NDC

64380018202

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079182

FDA Approved

4/19/2013

TE Code

AB

On Market Since

10/1/2022

Pharmacological Classes

Alkalinizing Activity
Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$7.8063 per EA
All-time high$18.3227 (May 15, 2024)
All-time low$7.0490 (Sep 17, 2025)
52-week high$8.0781
52-week low$7.0490
Median price$8.0781
Average price$9.6027
Largest weekly change-18.1% (Jul 17, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

+5.9%

1M

+5.9%

3M

+2.7%

6M

-3.4%

1Y

+7.7%

3Y

N/A

5Y

N/A

All

-57.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OMEPRAZOLE-BICARB 20-1,680 PKT?

The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 20-1,680 PKT, manufactured by Strides Pharma Inc., is $7.8063 per EA (NDC 64380018202), effective Aug 19, 2026.

How has the price of OMEPRAZOLE-BICARB 20-1,680 PKT changed over time?

Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has declined 57.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 20-1,680 PKT?

Since Apr 17, 2024, the NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has ranged from a low of $7.0490 (Sep 17, 2025) to a high of $18.3227 (May 15, 2024), with a median of $8.0781 per EA.

Are there cheaper alternatives to OMEPRAZOLE-BICARB 20-1,680 PKT?

No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 20-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OMEPRAZOLE-BICARB 20-1,680 PKT?

OMEPRAZOLE-BICARB 20-1,680 PKT (NDC 64380018202) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.